| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 30 Oct 2025 | 0001231589 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $1,489,620 | +11,000 | +30% | $135.42 | 47,781 | 30 Oct 2025 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | $287,195 | -642 | -1.3% | $447.34 | 47,139 | 30 Oct 2025 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $512,706 | -1,143 | -2.4% | $448.56 | 45,996 | 30 Oct 2025 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $1,546,606 | -3,441 | -7.5% | $449.46 | 42,555 | 30 Oct 2025 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $1,012,579 | -2,247 | -5.3% | $450.64 | 40,308 | 30 Oct 2025 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $834,952 | -1,849 | -4.6% | $451.57 | 38,459 | 30 Oct 2025 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $581,243 | -1,285 | -3.3% | $452.33 | 37,174 | 30 Oct 2025 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $178,480 | -393 | -1.1% | $454.15 | 36,781 | 30 Oct 2025 | Direct | F1, F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | $0 | -11,000 | -33% | $0.000000 | 22,000 | 30 Oct 2025 | Common Stock | 11,000 | $135.42 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. |
| F2 | This transaction was executed in multiple trades at prices ranging from $446.855 to $447.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $447.94 to $448.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $448.95 to $449.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $450.03 to $451.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $451.04 to $452.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $452.10 to $452.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $453.90 to $454.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |